🩺 Arvo
Automated medical-claim validation.
Quick facts
- Country
- Brazil
- Sector
- Health AI
- Latest disclosed round
- Series A
- Amount
- US$20M
- Backers
- Kaszek, Base10
- Reviewed
About
Backed by Kaszek, Base10, as publicly reported.
What "Series A" means
the first fully institutional round, raised once a company has a working business model and is scaling it — typically led by a venture fund writing a meaningfully larger cheque than seed investors. Failure rates drop from here, but are still substantial.
Why health ai is attracting capital
Health and biotech is one of the busiest early-stage categories across Latin America right now, spanning AI-assisted diagnostics, telehealth and admin automation for clinics — all sectors where regulatory approval and clinical validation, not just software, become the real bottleneck to scale.
Before you read anything into this
Arvo is not investable by the general public — this round was private, and nothing on this page is a recommendation, a rating or a prediction. Inclusion on our early-stage watchlist means a credible public source reported this round with a named stage; we have not done diligence on the company and have no view on its prospects. Most early-stage startups fail.
Understand the actual routes into deals like this one:
How to invest in startups →